CDK8-IN-3
CDK8-IN-3 is an inhibitor of CDK8 extracted from patent WO2016041618A1, compound example 1.7.
Product Specifications
CAS Number
1884500-15-5
UNSPSC
12352005
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Cancer; Metabolic Disease; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/CDK8-IN-3.html
Purity
98.17
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C(NCCOC)C1=CC=C2C(C(CC3=CC=C(C4=CN(C)N=C4)C=C3)=NN2)=C1
Molecular Formula
C22H23N5O2
Molecular Weight
389.45
References & Citations
[1]Kai S, et al. Preparation of substituted indazoles as CDK8 inhibitors for treatment of proliferative diseases. WO 2016041618 A1 20160324
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K6051203 1.0 µg DNA
RGD1308907 sgRNA CRISPR Lentivector (Rat) (Target 2)
Sign In for Pricing
View Details ![Rabbit Polyclonal SLX4 Antibody [PE]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
